View Older Stories View More Recent Stories

Sep 21, 2020 08:30AM Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT® Platform to Textiles Including Those Used in Personal Protective Equipment
Sep 16, 2020 04:00AM Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate
Sep 2, 2020 08:00AM Applied DNA to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15
Aug 27, 2020 12:38PM Applied DNA Provides Update on Status of New York State Laboratory Permit for Clinical Labs Subsidiary
Aug 17, 2020 06:00AM Applied DNA Positions LinearDNA™ Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
Aug 12, 2020 08:01AM Applied DNA Sciences (APDN) Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging
Aug 12, 2020 08:00AM Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging
Aug 6, 2020 04:05PM Applied DNA Reports Fiscal Third Quarter 2020 Financial Results
Jul 31, 2020 08:03AM Applied DNA Sciences (APDN) Announces FDA Approves EUA Amendment Increasing COVID-19 Diagnostic Kit Testing Capacity
Jul 31, 2020 08:00AM FDA Approves EUA Amendment Increasing Applied DNA’s COVID-19 Diagnostic Kit Testing Capacity Through Use of Automated RNA Extraction and Expands Supported Platforms
Jul 30, 2020 11:29AM Applied DNA to Report Fiscal 2020 Third Quarter Financial Results After Market Close on August 6, 2020
Jul 17, 2020 09:29AM Pre-Open Movers 07/17: (APDN) (OCN) (HMHC) Higher; (NIO) (NFLX) (ROKU) Lower (more...)
Jul 17, 2020 06:22AM Applied DNA Sciences (APDN), Takis Biotech Announce Positive Preclinical Results from LineaDNA Vaccine Candidates for COVID-19
Jul 17, 2020 06:20AM Applied DNA and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
Jul 15, 2020 07:00AM Applied DNA Appoints New Head of Investor Relations and Corporate Communications
Jul 9, 2020 06:03AM Applied DNA Sciences (APDN) Reports Formation of Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea COVID-19 Assay Kit
Jul 9, 2020 05:00AM Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea™ COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment
Jun 26, 2020 07:00AM Applied DNA Sciences Set to Join Russell Microcap Index
Jun 9, 2020 11:33AM Applied DNA Sciences (APDN) Announces Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates
Jun 9, 2020 11:33AM Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates
Jun 8, 2020 08:27AM Applied DNA Sciences (APDN) Provides Update on Linear-DNA COVID-19 Vaccine Candidates Development Program
Jun 8, 2020 08:26AM Applied DNA Provides Update on Linear-DNA COVID-19 Vaccine Candidates Development Program
May 21, 2020 11:11AM Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
May 14, 2020 04:05PM Applied DNA Reports 2020 Fiscal Second Quarter Financial Results
May 14, 2020 06:12AM Applied DNA Sciences (APDN) Granted FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
May 14, 2020 05:00AM Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
May 7, 2020 08:00AM Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET
May 6, 2020 08:00AM Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise
May 5, 2020 09:32AM Applied DNA Sciences (APDN) Applies to U.S. FDA for Emergency Use Authorization for COVID-19 Diagnostic Kit
May 5, 2020 09:32AM Applied DNA Applies to U.S. FDA for Emergency Use Authorization for COVID-19 Diagnostic Kit
May 4, 2020 09:03AM Applied DNA Sciences (APDN) Gains as Covid-19 Vaccine Shows Neutralizing Antibodies in Animals
May 4, 2020 03:00AM Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
Apr 30, 2020 11:01AM Applied DNA Sciences (APDN) announces ETT of FDA has accepted Company into its Emerging Technology Program for molecular tagging
Apr 30, 2020 10:59AM Applied DNA Accepted Into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging
Apr 21, 2020 02:00AM Applied DNA High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital
Apr 15, 2020 06:03AM Applied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing
Apr 14, 2020 08:30AM Applied DNA to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5
Apr 2, 2020 08:19AM Applied DNA Sciences (APDN) and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate
Apr 2, 2020 08:18AM Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate
Mar 26, 2020 08:37AM Applied DNA Ships LinearDNA™ to Another Development Customer
Mar 24, 2020 07:05AM Applied DNA Sciences (APDN) Files Provisional Patent Application for High Sensitivity COVID-19 Diagnostic Assay with USPTO
Mar 24, 2020 07:00AM Applied DNA Files Provisional Patent Application for High Sensitivity COVID-19 Diagnostic Assay with U.S. Patent and Trademark Office
Mar 20, 2020 11:29AM Applied DNA Secures Global Top-20 Pharmaceutical Manufacturer as Drug Development Customer
Mar 19, 2020 07:01AM Applied DNA Sciences (APDN) Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design High Sensitivity Diagnostic Kit for Virus Detection
Mar 19, 2020 07:00AM Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection
Mar 18, 2020 03:05PM Applied DNA Sciences (APDN) Confirms COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of Vaccine Candidate on Pre-clinical Models
Mar 18, 2020 03:04PM Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-clinical Models
Mar 2, 2020 09:24AM Pre-Open Stock Movers 03/02: (FTSV) (TRIL) (TWTR) Higher; (BIOC) (ENLV) (NVAX) Lower (more...)
Mar 2, 2020 06:28AM Applied DNA Sciences (APDN) Updates on COVID-19 Collaboration with Takis Biotech
Mar 2, 2020 04:00AM Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
View More Recent Stories View Older Stories